Clinical Trial Update: Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating transarterial chemoembolization (TACE) plus bevacizumab for liver metastases. The study is in Phase 1/2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Pardis Noor Medical Imaging and Cancer Center | Conditions: Cancer, Metastatic Cancer | Phase 1, Phase 2 | Status: RECRUITING